These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 7561949)

  • 21. Lewy body disease and dementia. A review.
    Kalra S; Bergeron C; Lang AE
    Arch Intern Med; 1996 Mar; 156(5):487-93. PubMed ID: 8604954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
    Court JA; Piggott MA; Lloyd S; Cookson N; Ballard CG; McKeith IG; Perry RH; Perry EK
    Neuroscience; 2000; 98(1):79-87. PubMed ID: 10858614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein.
    Savage MJ; Iqbal M; Loh T; Trusko SP; Scott R; Siman R
    Neuroscience; 1994 Jun; 60(3):607-19. PubMed ID: 7936190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease.
    Almeida OP; Burton EJ; McKeith I; Gholkar A; Burn D; O'Brien JT
    Dement Geriatr Cogn Disord; 2003; 16(2):57-63. PubMed ID: 12784028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease.
    Tunold JA; Tan MMX; Koga S; Geut H; Rozemuller AJM; Valentino R; Sekiya H; Martin NB; Heckman MG; Bras J; Guerreiro R; Dickson DW; Toft M; van de Berg WDJ; Ross OA; Pihlstrøm L
    Brain; 2023 Oct; 146(10):4077-4087. PubMed ID: 37247383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of lysosomal cathepsins in neurodegeneration: Mechanistic insights, diagnostic potential and therapeutic approaches.
    Drobny A; Prieto Huarcaya S; Dobert J; Kluge A; Bunk J; Schlothauer T; Zunke F
    Biochim Biophys Acta Mol Cell Res; 2022 Jul; 1869(7):119243. PubMed ID: 35217144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicatalytic proteinase is associated with characteristic oval structures in cortical Lewy bodies: an immunocytochemical study with light and electron microscopy.
    Masaki T; Ishiura S; Sugita H; Kwak S
    J Neurol Sci; 1994 Apr; 122(2):127-34. PubMed ID: 8021694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease.
    Perry EK; McKeith I; Thompson P; Marshall E; Kerwin J; Jabeen S; Edwardson JA; Ince P; Blessed G; Irving D
    Ann N Y Acad Sci; 1991; 640():197-202. PubMed ID: 1723256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac sympathetic denervation and synucleinopathy in Alzheimer's disease with brain Lewy body disease.
    Serrano GE; Shprecher D; Callan M; Cutler B; Glass M; Zhang N; Walker J; Intorcia A; Adler CH; Shill HA; Driver-Dunckley E; Mehta SH; Belden CM; Zamrini E; Sue LI; Vargas D; Beach TG
    Brain Commun; 2020; 2(1):fcaa004. PubMed ID: 32064463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly.
    Ii K; Ito H; Tanaka K; Hirano A
    J Neuropathol Exp Neurol; 1997 Feb; 56(2):125-31. PubMed ID: 9034365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal accumulation of phospholipase C-delta in filamentous inclusions of human neurodegenerative diseases.
    Shimohama S; Perry G; Richey P; Takenawa T; Whitehouse PJ; Miyoshi K; Suenaga T; Matsumoto S; Nishimura M; Kimura J
    Neurosci Lett; 1993 Nov; 162(1-2):183-6. PubMed ID: 8121625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Pathology and Electroencephalographic Activity in Parkinson's Disease.
    Caviness JN; Beach TG; Hentz JG; Shill HA; Driver-Dunckley ED; Adler CH
    Clin EEG Neurosci; 2018 Sep; 49(5):321-327. PubMed ID: 29161906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of aminopeptidase, dipeptidyl aminopeptidase and tripeptidyl aminopeptidase activities in brain tissue from normal and Alzheimer's disease cases.
    Mantle D; Perry EK
    J Neurol Sci; 1990 Aug; 98(1):13-20. PubMed ID: 2230828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.
    Cisbani G; Maxan A; Kordower JH; Planel E; Freeman TB; Cicchetti F
    Brain; 2017 Nov; 140(11):2982-2992. PubMed ID: 29069396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
    Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K
    Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study.
    Ala TA; Yang KH; Sung JH; Frey WH
    J Neurol Neurosurg Psychiatry; 1997 Jan; 62(1):16-21. PubMed ID: 9010394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies.
    Beyer K; Domingo-Sàbat M; Santos C; Tolosa E; Ferrer I; Ariza A
    Brain; 2010 Dec; 133(Pt 12):3724-33. PubMed ID: 20959308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropathologic features of Parkinson's, Huntington's, and Alzheimer's diseases.
    Forno LS
    Ann N Y Acad Sci; 1992 May; 648():6-16. PubMed ID: 1386207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.